Comparative Effectiveness of a Breath-Operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
Information source: IVAX Research LLC
Information obtained from ClinicalTrials.gov on March 24, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Asthma
Intervention: Albuterol (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: IVAX Research LLC
Summary
This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in
asthma patients who have difficulty using their standard "press-and-breathe" inhaler.
Clinical Details
Study design: Treatment
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Stable asthma
- Poor inhaler coordination technique.
Exclusion Criteria:
- Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting
beta-blockers, steroids other than those inhaled
Locations and Contacts
National Jewish Medical and Research Center, Denver, Colorado 80206, United States
Additional Information
Starting date: March 2003
Last updated: June 23, 2005
|